Riociguat is Formulary, Restricted to Patient’s Own Medication or continuation of home medication; the product is not routinely stocked by sites due to the REMS program.  

The goal of the Riociguat shared system REMS is to mitigate the risk of embryo-fetal toxicity, and includes health care provider, patient, pharmacy and wholesaler-distributor requirements for dispensing.

See Legacy Health REMS Requirements for detail.

• Micromedex
• CareNotes
• UpToDate
• Facts & Comparisons
• MedLinePlus (Patient Information)